Related Experiment Video
Updated: Aug 14, 2026

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent
Published on: November 1, 2013
Topical Application of the Antimicrobial Agent Triclosan Induces NLRP3 Inflammasome Activation and Mitochondrial
Lisa M Weatherly1, Hillary L Shane1, Sherri A Friend2
1Allergy and Clinical Immunology Branch.
Abstract:
5-Chloro-2-(2,4-dichlorophenoxy)phenol (triclosan) is an antimicrobial chemical widely used in consumer household and clinical healthcare products. Human and animal studies have associated triclosan exposure with allergic disease. Mechanistic studies have identified triclosan as a mitochondrial uncoupler; recent studies suggest that mitochondria play an important role in immune cell function and are involved in activation of the NLRP3 inflammasome. In this study, early immunological effects were evaluated via NLRP3 activation following dermal triclosan application in a BALB/c murine model. These investigations revealed rapid caspase-1 activation and mature IL-1β secretion in the skin and draining lymph nodes (dLNs) after 1.5% and 3% triclosan exposure. Correspondingly, pro-Il-1b and S100a8 gene expression increased along with extracellular ATP in the skin. Peak gene expression of chemokines associated with caspase-1 activation occurred after 2 days of exposure in both skin tissue and dLNs. Phenotypic analysis showed an increase in neutrophils and macrophages in the dLN and myeloid and inflammatory monocytes in the skin tissue. Triclosan also caused mitochondrial dysfunction shown through effects on mitochondrial reactive oxygen species, mass, mitochondrial membrane potential, and mitochondrial morphology. These results indicate that following triclosan exposure, activation of the NLRP3 inflammasome occurs in both the skin tissue and dLNs, providing a possible mechanism for triclosan's effects on allergic disease and further support a connection between mitochondrial involvements in immunological responses.
Insights
Triclosan, an antimicrobial chemical, triggers NLRP3 inflammasome activation in skin and lymph nodes, potentially explaining its link to allergic diseases. This involves immune cell changes and mitochondrial dysfunction.
Area of Science:
- Immunology
- Toxicology
- Cell Biology
Background:
- Triclosan is a widely used antimicrobial in consumer and clinical products.
- Human and animal studies link triclosan exposure to allergic diseases.
- Mitochondria are crucial for immune cell function and NLRP3 inflammasome activation.
Purpose of the Study:
- To investigate early immunological effects of dermal triclosan exposure.
- To evaluate NLRP3 inflammasome activation following triclosan application in a murine model.
- To explore the connection between mitochondrial dysfunction and immune responses induced by triclosan.
Main Methods:
- Dermal application of triclosan (1.5% and 3%) in BALB/c mice.
- Measurement of caspase-1 activation and IL-1β secretion in skin and draining lymph nodes (dLNs).
- Analysis of gene expression (pro-Il-1b, S100a8, chemokines), extracellular ATP, and immune cell phenotypes.
- Assessment of mitochondrial function (ROS, mass, membrane potential, morphology).
Main Results:
- Rapid caspase-1 activation and IL-1β secretion in skin and dLNs post-triclosan exposure.
- Increased pro-Il-1b, S100a8 gene expression, and extracellular ATP in the skin.
- Upregulated chemokine gene expression and increased neutrophils, macrophages, monocytes in skin and dLNs.
- Triclosan induced mitochondrial dysfunction affecting ROS, mass, membrane potential, and morphology.
Conclusions:
- Dermal triclosan exposure activates the NLRP3 inflammasome in skin and dLNs.
- This activation involves immune cell infiltration and mitochondrial dysfunction.
- NLRP3 inflammasome activation provides a potential mechanism for triclosan-associated allergic diseases.
More Related Videos
Related Concept Videos
Microbial Corrosion
Dysbiosis of the Gut Microbiota
Trichomoniasis
Clinical Significance of Antibiotic Resistance
Inflammatory Bowel Disease III: Crohn's Disease
Antiprotozoal Agents

